Current practice in Europe: How do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey

Europace

Volumn 15, Issue 2, 2013, Pages 167-169

  Proclemer, Alessandro ^a   Dagres, Nikolaos ^b   Marinskis, Germanas ^c   Pison, Laurent ^d   Lip, Gregory Y H ^e   Blomstrom Lundqvist, Carina ^f  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c VILNIUS UNIVERSITY   (Lithuania)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

EHRA survey; Ventricular tachycardia

Indexed keywords

ANTIARRHYTHMIC AGENT;

CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL PRACTICE; CONGESTIVE CARDIOMYOPATHY; EUROPE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTATION; ISCHEMIC HEART DISEASE; MEDICAL SOCIETY; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; REVIEW; ARTICLE; CARDIAC IMAGING; CATHETER ABLATION; FEMALE; HEALTH CARE SURVEY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANTI-ARRHYTHMIA AGENTS; CARDIAC IMAGING TECHNIQUES; CARDIOMYOPATHY, DILATED; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; EUROPE; FEMALE; HEALTH CARE SURVEYS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; STROKE VOLUME; TACHYCARDIA, VENTRICULAR;

MLCS; MLOWN;

EID: 84879724966     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus436     Document Type: Review

References (17)

1. Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH, Delacretaz E et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 2009;11:771-817.
2. Wissner E, Stevenson WG, Kuck KH. Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: Where are we today? A clinical review. Eur Heart J 2012;33:1440-50.
3. Zeppenfeld K. Ventricular tachycardia ablation in implantable cardioverter-defibrillator recipients: A need to catch up with current recommendations. Europace 2012;14:778-80.
4. Proclemer A, Dobreanu D, Pison L, Lip GY, Svendsen JH, Lundqvist CB. Current practice in out-of-hospital cardiac arrest management: A European Heart Rhythm Association EP network survey. Europace 2012;14:1195-8.
5. Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Fioretti P et al. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: Data from the Italian ICD Registry for the years 2005-07. Europace 2009;11:465-75.
6. Bogun FM, Desjardins B, Good E, Gupta S, Crawford T, Oral H et al. Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: Utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol 2009;53:1138-45.
7. White JA, Fine NM, Gula L, Yee R, Skanes A, Klein G et al. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging 2012;5:12-20.
8. Deneke T, Lemke B, Mugge A, Shin DI, Grewe PH, Horlitz M et al. Catheter ablation of electrical storm. Expert Rev Cardiovasc Ther 2011;9:1051-8.
9. Mallidi J, Nadkarni GN, Berger RD, Calkins H, Nazarian S. Meta-Analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm 2011;8:503-10.
10. Gaffney AM, Wildhirt SM, Griffin MJ, Annich GM, Radomski MW. Extracorporeal life support. BMJ 2010;341:c5317.
11. John RM, Stevenson WG. Ventricular arrhythmias in patients with implanted cardioverter defibrillators. Trends Cardiovasc Med 2012;22:169-73.
12. Kozeluhova M, Peichl P, Cihak R, Wichterle D, Vancura V, Bytesnik J et al. Catheter ablation of electrical storm in patients with structural heart disease. Europace 2011;13:109-13.
13. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
14. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-65.
15. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacretaz E et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): A multicentre randomised controlled trial. Lancet 2010;375:31-40.
16. Sacher F, Roberts-Thomson K, Maury P, Tedrow U, Nault I, Steven D et al. Epicardial ventricular tachycardia ablation a multicenter safety study. J Am Coll Cardiol 2010;55:2366-72.
17. Dagres N, Cantu F, Geelen P, Lewalter T, Proclemer A, Blomstrom-Lundqvist C. Current practice of ventricular tachycardia ablation in patients with implantable cardioverter-defibrillators. Europace 2012;14:135-7.